Karimian, Ava
Karimzadeh, Iman
Shafiekhani, Mojtaba
Heidari, Reza
Masjedi, Fatemeh
Izadi, Fatemeh
Barshan-Tashnizi, Nazanin
Kane-Gill, Sandra L.
Mahmoudi, Laleh
Funding for this research was provided by:
The Vice-Chancellery of Research and Technology of Shiraz University of Medical Sciences financially supported this study (27326, 27326)
Article History
Received: 19 June 2024
Accepted: 8 August 2024
First Online: 23 September 2024
Declarations
:
: The local Ethics Committee of Shiraz University of Medical Sciences (SUMS) approved the study protocol (reference number: IR.SUMS.REC.1402.073) and registered on the Iranian registry of clinical trials as IRCT20161010030246N6 at May 27, 2023. All participants were explained and informed for protocol of study and signed written consent forms.
: Not applicable.
: Sandra L Kane-Gill receives grant funding from the National Institute of Diabetes and Digestive and Kidney Diseases R01DK121730 and U01DK130010, the National Center for Complementary and Integrative Health U54AT008909 and the Jewish Healthcare Foundation. Other authors declare no competing interests.